Fujirebio Announces CE Marking of the Fully Automated Lumipulse® G pTau 217 Plasma Assay


Fujirebio is a diagnostics company with over 75 years of experience delivering innovative solutions to healthcare providers, pharmaceutical companies, and in vitro diagnostics (IVD) partners worldwide. Leveraging world-class expertise in neurology, oncology, infectious diseases, and beyond, and assays available on the robust LUMIPULSE G platform, Fujirebio’s open business model accelerates access to breakthrough diagnostics through strategic partnerships across the life science industry.



Source link

  • Related Posts

    The cage match is on for tickets to Trump’s UFC fight at the White House

    As something of a professional Republican, April Melton has attended her fair share of ho-hum events in the nation’s capital. But there’s one coming up that the chair of the…

    Who’s Lobbying Whom: May 11, 2026

    Lobbying Activity Reports are a monthly detailed record of specific interactions, including actual communications with senior public office holders (ministers, MLAs, deputy ministers, etc.). Source: Office of the Registrar of…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    How will L.A. rise from the ashes?

    How will L.A. rise from the ashes?

    After Wemby’s ejection, Spurs coach calls out refs for how star center is officiated

    After Wemby’s ejection, Spurs coach calls out refs for how star center is officiated

    Éric Duhaime is hoping to make ‘history’ with Quebec Conservatives

    The cage match is on for tickets to Trump’s UFC fight at the White House

    The cage match is on for tickets to Trump’s UFC fight at the White House

    Crimson Desert Update 1.06.00 Out Now — Check Out the Patch Notes

    Crimson Desert Update 1.06.00 Out Now — Check Out the Patch Notes

    Xi, confident in China’s power, is ready to host an unpredictable Trump

    Xi, confident in China’s power, is ready to host an unpredictable Trump